Dermatology Devices Market Size, Growth by Type (Diagnostic Devices (Dermatoscopes, Imaging Devices), Treatment Devices (Laser, Cryotherapy, Liposuction)), Application (Skin Cancer, Acne, Psoriasis, Skin Rejuvenation, Tattoo Removal) & Region - Global Forecasts to 2027
Updated on : March 24, 2023
The global dermatology devices market in terms of revenue was estimated to be worth $6.2 billion in 2022 and is poised to reach $11.3 billion by 2027, growing at a CAGR of 12.7% from 2022 to 2027.
Growth in this market driven by the rising incidence of skin diseases and increasing awareness of aesthetic procedures. The expansion of healthcare infrastructure in developing regions is expected to provide growth opportunities to players operating in this market. However, reimbursement issues and stringent regulatory policies for medical devices are estimated to restrain the growth of this market.Dermatology devices help dermatologists and surgeons in diagnosing and treating skin disorders. These devices are used by various medical care providers, such as hospitals, dermatology clinics, physician offices, and academic research institutes.
To know about the assumptions considered for the study, Request for Free Sample Report
Dermatology Devices Market Dynamics
Drivers: Rising adoption of aesthetic procedures among geriatric individuals
The process of aging is associated with progressive deterioration of the skin. Subsequently, the demand for aesthetic procedures, such as anti-wrinkle treatment and skin tightening, is expected to grow among the elderly.
Opportunities: Growing adoption of minimally invasive and non-invasive aesthetic procedures
In the past decade, there has been a significant increase in the preference for minimally invasive and non-invasive aesthetic procedures over traditional surgical procedures. Minimally invasive/non-surgical alternatives offer various advantages over traditional surgical procedures, such as less pain, reduced scarring, and quicker recovery. These procedures are also more economical than traditional surgical procedures.
The increasing demand for aesthetic procedures is driving the market for treatment devices as well as aesthetic lasers and cosmetic dermatology. These lasers are used in aesthetic procedures such as hair removal, skin rejuvenation, acne, psoriasis, tattoo removal, wrinkle removal, skin resurfacing, vascular lesions, and pigmented lesions, among other skin diseases. Lasers with longer wavelengths and better configurations have expanded the range of beauty treatments, making the aesthetic lasers industry a lucrative one. This market is being driven primarily by the more expensive CO2 and YAG laser systems, which can sell for more than USD 50,000 each and have gained tremendous popularity amongst users.
With the growth in the number of minimally invasive and non-invasive aesthetic procedures, the demand for several products, including botulinum toxin, chemical peels, and photo rejuvenation products, is expected to increase in the coming years.
Restraints: Clinical risks and complications associated with dermatology procedures
In the last two decades, dermatology procedures have become increasingly popular. The market has witnessed significant growth in the demand for aesthetic treatments owing to the rise in the number of doctors and surgeons providing safe and effective dermatology treatments and the launch of technologically advanced products for the same. However, dermatology procedures are associated with various possible side effects. Patients undergoing aesthetic treatments may face several risks and complications after or during the procedure. Some of these risks are listed below:
- Pigment changes: Laser hair removal might darken or lighten the affected skin. These changes might be temporary or permanent. Skin lightening primarily affects those who do not avoid sun exposure before or after treatment and those who have darker skin
- Skin irritation: Laser hair removal can cause temporary discomfort, redness, and edema. Any signs and symptoms usually go away after a few hours
Other issues related to aesthetic treatments include anesthesia-related complications, organ damage, and infections. Red light therapy is thought to be painless and safe. However, there have been complaints of RLT units causing burns and blisters. Burns were reported in a few people after they fell asleep with the unit on, while others were burned by damaged wires or gadget corrosion. Although less harmful to the eyes than typical lasers, red light therapy may necessitate the use of eye protection. These problems are expected to hamper the adoption of dermatology treatments.
The imaging devices are accounted to hold the highest CAGR of the dermatology devices market, by type during forecast period.
Based on type, the market is segmented into imaging devices, dermatoscopes, and microscopes. During forecasted period, the imaging devices segment accounted for the highest CAGR of the dermatology diagnostic devices market. The highest CAGR of this segment can be attributed to technological advancements and the increasing incidence of skin diseases.
The skin cancer diagnosis are accounted to hold the highest CAGR of the dermatology devices market, by application during forecasted period.
Based on application, the market is segmented into skin cancer diagnosis and other diagnostic applications. During forecasted period, the skin cancer diagnosis segment accounted for the highest CAGR of the market. The highest CAGR of this segment can be attributed to the rising incidence of skin cancer.
To know about the assumptions considered for the study, download the pdf brochure
North America commanded the largest share of the dermatology devices market.
Based on region, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America has the largest share of the global market. The large share of this regional segment can be attributed to factors such as the rising incidence of skin diseases, increased awareness about aesthetic procedures, rapid increase in healthcare expenditure, easy accessibility to advanced technologies, and the strong presence of market players in the region.
The major players operating in this market are Alma Lasers, Ltd. (a subsidiary of Sisram Medical Ltd.) (Israel), Cutera, Inc. (US), Cynosure Inc. (US), El.En. S.p.A.(Italy), Lumenis, Ltd. (a subsidiary of Boston Scientific) (Israel), Solta Medical (a subsidiary of Bausch Health Companies Inc.) (US), Bruker Corporation (US), Carl Zeiss (Germany), Candela Corporation (US), Genesis Biosystems, Inc. (US), HEINE Optotechnik GmbH & Co. KG (Germany), Michelson Diagnostics Ltd. (UK), PhotoMedex, Inc. (US), Leica Microsystems (a subsidiary of Danaher Corporation) (US), Olympus Corporation (Japan), FotoFinder Systems GmbH (Germany), Canfield Scientific, Inc. (US), Beijing Toplaser Technology Co., Ltd. (China), DermLite (US), Syneron Medical Ltd. (a part of Apax Partners) (US), Aerolase (US), and Bovie (a subsidiary of Symmetry Surgical) (US).
Dermatology Devices Market Report Scope:
|
Report Metrics |
Details |
|
Market Size value 2027 |
USD 11.3 billion |
|
Growth Rate |
12.7% CAGR |
|
Largest Market |
North America |
|
Market Dynamics |
Drivers, Opportunities, Restraints & Challenges |
|
Largest Share Segments |
The imaging devices, The skin cancer diagnosis |
|
Forecasts up to |
2027 |
|
Market Segmentation |
By Type, application, and region |
|
Dermatology Devices Market Growth Drivers |
|
|
Dermatology Devices Market Growth Opportunities |
|
|
Geographies covered |
North America (the US and Canada), Europe (Germany, France, UK, Italy, Spain, and the RoE), APAC (Japan, China, India, and the RoAPAC), and the Rest of the World (RoW) (the Middle East & Africa and Latin America) |
This research report categorizes the dermatology devices market into the following segments and sub-segments:
By Product
-
Dermatology diagnostics devices, by Type
- Dermatoscopes
- Microscopes
- Imaging Devices
-
Dermatology treatment devices, by Type
- Light Therapy Devices
- Lasers
- Electrosurgical Equipment
- Liposuction Devices
- Microdermabrasion Devices
- Cryotherapy Devices
By Application
-
Dermatology diagnostics devices, by Application
- Skin Cancer Diagnosis
- Other Diagnostic Applications
-
Dermatology treatment devices, by Application
- Hair Removal
- Skin Rejuvenation
- Acne, Psoriasis, and Tattoo Removal
- Wrinkle Removal and Skin Resurfacing
- Body Contouring and Fat Removal
- Vascular and Pigmented Lesion Removal
- Warts, Skin Tags, and Weight Management
- Other Treatment Applications
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
-
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
-
Rest of the World
- Latin America
- Middle East & Africa
Key developments:
- In 2022, Cynosure, Inc. collaborated with Clayton, Dubilier & Rice and announced a new investment of USD 60 million from lead investor Clayton, Dubilier & Rice
- In 2021, Lumenis entered into a definitive agreement to sell the Lumenis Surgical Business to Boston Scientific. The acquisition of Lumenis Surgical (including its robust product portfolio, global team, and the Israeli surgical laser center of excellence) represents a major milestone for the Lumenis team and will enable Boston Scientific to enhance the execution of its urology strategy.
- In 2022, Candela collaborated with The Vascular Birthmarks Foundation, Dr. Giacomo Colletti, Laserplast, this collaboration enabled more than 30 pre-qualified patients from 13 countries to receive free laser treatments in Milan
- In 2022, Canfield Scientific, Inc. acquired Medici Medical s.r.l. to create Canfield Scientific s.r.l., open a state-of-the-art facility near Modena, and launch a medical dermatology education program.
- In 2021, Alma launched Alma PrimeX, a non-invasive platform for body contouring and skin tightening.
- In 2021, Alma launched Alma Hybrid, which exclusively combines 3 powerful energy sources to deliver effective results.
Frequently Asked Questions (FAQs):
What is the projected market value of the global Dermatology Devices Market?
The global market of Dermatology Devices is projected to reach USD 11.3 billion.
What is the estimated growth rate (CAGR) of the global Dermatology Devices Market for the next five years?
The global Dermatology Devices Market is projected to grow at a Compound Annual Growth Rate (CAGR) of 12.7 % from 2022 to 2027.
What are the major revenue pockets in the Dermatology Devices Market currently?
North America has the largest share of the global market. The large share of this regional segment can be attributed to factors such as the rising incidence of skin diseases, increased awareness about aesthetic procedures, rapid increase in healthcare expenditure, easy accessibility to advanced technologies, and the strong presence of market players in the region.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 30)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 35)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY – BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF DERMATOLOGY TREATMENT DEVICES
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY – BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF DERMATOLOGY DIAGNOSTIC DEVICES
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 9 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT/FACTOR ANALYSIS
TABLE 1 RISK ANALYSIS
3 EXECUTIVE SUMMARY (Page No. - 48)
FIGURE 11 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022 VS. 2027
FIGURE 12 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2022 VS. 2027
FIGURE 13 DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2022 VS. 2027
FIGURE 14 DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2022 VS. 2027
FIGURE 15 DERMATOLOGY DEVICES MARKET, BY REGION, 2022 VS. 2027
4 PREMIUM INSIGHTS (Page No. - 52)
4.1 DERMATOLOGY DEVICES MARKET OVERVIEW
FIGURE 16 RISING INCIDENCE OF SKIN DISEASES TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE (2021)
FIGURE 17 IMAGING DEVICES SEGMENT DOMINATED APAC MARKET IN 2021
4.3 GEOGRAPHICAL SNAPSHOT OF DERMATOLOGY DEVICES MARKET
FIGURE 18 JAPAN TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 54)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 DERMATOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising incidence of skin disorders
5.2.1.2 Availability of technologically advanced and user-friendly products
5.2.1.3 Growing adoption of minimally invasive and non-invasive aesthetic procedures
5.2.1.4 Rising adoption of aesthetic procedures among geriatric individuals
FIGURE 20 INCREASE IN GERIATRIC POPULATION, BY COUNTRY (2011 VS. 2015 VS. 2030)
FIGURE 21 INCREASE IN PROPORTION OF GERIATRIC INDIVIDUALS IN OVERALL POPULATION, BY COUNTRY (2011 VS. 2015 VS. 2030)
5.2.1.5 Increasing investments, funds, and grants by public-private organizations
TABLE 2 KEY INVESTMENTS BY GOVERNMENT BODIES IN THE DIAGNOSTIC IMAGING MARKET
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulatory policies for medical devices
5.2.2.2 Clinical risks and complications associated with dermatology procedures
5.2.2.3 High cost of diagnostic imaging systems
5.2.2.4 Declining reimbursements and increasing regulatory burden in the US
TABLE 3 MEDICARE REIMBURSEMENT TRENDS, BY IMAGING MODALITY, 2007–2019
5.2.3 OPPORTUNITIES
5.2.3.1 Growing medical devices industry in emerging economies
FIGURE 22 MEDICAL DEVICES MARKET, 2016–2020
5.2.3.2 Increasing disposable income and expanding middle-class population
5.2.4 CHALLENGES
5.2.4.1 Competitive pricing by low-cost manufacturers and availability of low-cost substitutes
5.2.4.2 Dearth of trained professionals
5.2.5 TRENDS
5.2.5.1 Importance of artificial intelligence and teleradiology in skin disorder diagnosis and treatment
5.3 COVID-19 IMPACT ANALYSIS
5.4 RANGES/SCENARIOS
5.4.1 DERMATOLOGY DEVICES MARKET
FIGURE 23 REALISTIC SCENARIO
FIGURE 24 PESSIMISTIC SCENARIO
FIGURE 25 OPTIMISTIC SCENARIO
5.5 REGULATORY ANALYSIS
TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING DERMATOLOGY DEVICES
5.5.1 NORTH AMERICA
5.5.1.1 US
TABLE 5 US FDA MEDICAL DEVICE CLASSIFICATION
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.1.2 Canada
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.2 EUROPE
5.5.3 ASIA PACIFIC
5.5.3.1 Japan
TABLE 8 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY
5.5.3.2 China
TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.5.3.3 India
5.6 PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 THREAT OF SUBSTITUTES
5.6.3 BARGAINING POWER OF SUPPLIERS
5.6.4 BARGAINING POWER OF BUYERS
5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 26 DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES
5.8 VALUE CHAIN ANALYSIS
FIGURE 27 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
5.9 ECOSYSTEM ANALYSIS
FIGURE 28 DERMATOLOGY DEVICES MARKET: ECOSYSTEM ANALYSIS
5.9.1 ROLE IN ECOSYSTEM
FIGURE 29 KEY PLAYERS IN DERMATOLOGY DEVICES MARKET ECOSYSTEM
5.10 TECHNOLOGY ANALYSIS
5.11 KEY CONFERENCES & EVENTS IN 2022–2023
TABLE 10 DERMATOLOGY DEVICES MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.12 PATENT ANALYSIS
5.12.1 PATENT TRENDS FOR DERMATOLOGY DEVICES
FIGURE 30 PATENT TRENDS FOR DERMATOSCOPES, JANUARY 2011–JUNE 2022
FIGURE 31 PATENT TRENDS FOR LIPOSUCTION DEVICES, JANUARY 2011–JUNE 2022
5.12.2 JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 32 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR DERMATOSCOPE PATENTS, JANUARY 2011—JUNE 2022
FIGURE 33 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR LIPOSUCTION DEVICE PATENTS, JANUARY 2011—JUNE 2022
5.13 TRADE ANALYSIS
TABLE 11 IMPORT DATA FOR HS CODE 901320, BY COUNTRY, 2017–2021
TABLE 12 EXPORT DATA FOR HS CODE 901320, BY COUNTRY, 2017–2021
5.14 PRICING ANALYSIS
TABLE 13 AVERAGE SELLING PRICES OF DERMATOLOGY DEVICES
TABLE 14 COST OF DERMATOLOGY TREATMENT DEVICES
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 34 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF DERMATOLOGY TREATMENT DEVICES
TABLE 15 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF DERMATOLOGY TREATMENT DEVICES (%)
5.15.2 BUYING CRITERIA
FIGURE 35 KEY BUYING CRITERIA FOR END USERS OF DERMATOLOGY TREATMENT DEVICES
TABLE 16 KEY BUYING CRITERIA FOR END USERS OF DERMATOLOGY TREATMENT DEVICES
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS
5.16.1 REVENUE SHIFT & REVENUE POCKETS FOR DERMATOLOGY DEVICE MANUFACTURERS
FIGURE 36 REVENUE SHIFT FOR DERMATOLOGY DEVICES
6 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE (Page No. - 93)
6.1 INTRODUCTION
TABLE 17 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027
6.2 IMAGING DEVICES
6.2.1 MRI, ULTRASOUND, CT, AND OCT ARE WIDELY USED IN DERMATOLOGY DISEASE DIAGNOSIS
TABLE 18 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR IMAGING DEVICES, BY REGION, 2020–2027
6.3 DERMATOSCOPES
6.3.1 INCREASING AWARENESS ABOUT SKIN HEALTH TO DRIVE SEGMENT GROWTH
TABLE 19 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR DERMATOSCOPES, BY REGION, 2020–2027
6.4 MICROSCOPES
6.4.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED MICROSCOPES — A KEY FACTOR DRIVING SEGMENT GROWTH
TABLE 20 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR MICROSCOPES, BY REGION, 2020–2027
7 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION (Page No. - 98)
7.1 INTRODUCTION
TABLE 21 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027
7.2 SKIN CANCER DIAGNOSIS
7.2.1 RISING PREVALENCE OF SKIN CANCER AND INCREASING AWARENESS ABOUT EARLY DIAGNOSIS TO DRIVE SEGMENT GROWTH
TABLE 22 NUMBER OF MELANOMA SKIN CANCER CASES, BY COUNTRY (2020)
TABLE 23 NUMBER OF NON-MELANOMA SKIN CANCER CASES, BY COUNTRY (2020)
TABLE 24 NUMBER OF MELANOMA SKIN CANCER DEATHS, BY COUNTRY (2020)
TABLE 25 NUMBER OF NON-MELANOMA SKIN CANCER DEATHS, BY COUNTRY (2020)
TABLE 26 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR SKIN CANCER DIAGNOSIS, BY REGION, 2020–2027
7.3 OTHER DIAGNOSTIC APPLICATIONS
TABLE 27 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027
8 DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE (Page No. - 103)
8.1 INTRODUCTION
TABLE 28 DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027
8.2 LIGHT THERAPY DEVICES
8.2.1 INCREASING DEMAND FOR SKIN REJUVENATION PROCEDURES TO DRIVE SEGMENT GROWTH
TABLE 29 DERMATOLOGY TREATMENT DEVICES MARKET FOR LIGHT THERAPY DEVICES, BY REGION, 2020–2027
8.3 LASERS
8.3.1 IMPROVING LASER TECHNOLOGY HAS REVOLUTIONIZED TREATMENTS FOR SEVERAL SKIN CONDITIONS
TABLE 30 DERMATOLOGY TREATMENT DEVICES MARKET FOR LASERS, BY REGION, 2020–2027
8.4 ELECTROSURGICAL EQUIPMENT
8.4.1 RISK OF ELECTROSURGICAL BURNS IS EXPECTED TO HINDER SEGMENT GROWTH
TABLE 31 DERMATOLOGY TREATMENT DEVICES MARKET FOR ELECTROSURGICAL EQUIPMENT, BY REGION, 2020–2027
8.5 LIPOSUCTION DEVICES
8.5.1 INCREASING OBESITY RATES TO DRIVE SEGMENT GROWTH
TABLE 32 DERMATOLOGY TREATMENT DEVICES MARKET FOR LIPOSUCTION DEVICES, BY REGION, 2020–2027
8.6 MICRODERMABRASION DEVICES
8.6.1 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE SEGMENT GROWTH
TABLE 33 DERMATOLOGY TREATMENT DEVICES MARKET FOR MICRODERMABRASION DEVICES, BY REGION, 2020–2027
8.7 CRYOTHERAPY DEVICES
8.7.1 COST-EFFECTIVE NATURE OF CRYOTHERAPY TO DRIVE ITS ADOPTION
TABLE 34 DERMATOLOGY TREATMENT DEVICES MARKET FOR CRYOTHERAPY DEVICES, BY REGION, 2020–2027
9 DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION (Page No. - 110)
9.1 INTRODUCTION
TABLE 35 DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027
9.2 HAIR REMOVAL
9.2.1 IPL, DIODE, ND:YAG, AND RUBY LASERS ARE WIDELY USED IN HAIR REMOVAL PROCEDURES
TABLE 36 LASER HAIR REMOVAL PROCEDURES: REGIONAL DISTRIBUTION (2020)
TABLE 37 DERMATOLOGY TREATMENT DEVICES MARKET FOR HAIR REMOVAL, BY REGION, 2020–2027
9.3 SKIN REJUVENATION
9.3.1 GROWING DEMAND FOR SAFE AND EFFECTIVE SKIN REJUVENATION TREATMENTS TO PROPEL SEGMENT GROWTH
TABLE 38 DERMATOLOGY TREATMENT DEVICES MARKET FOR SKIN REJUVENATION, BY REGION, 2020–2027
9.4 ACNE, PSORIASIS, AND TATTOO REMOVAL
9.4.1 EMERGENCE OF LASER TECHNOLOGY FOR TATTOO REMOVAL TO DRIVE SEGMENT GROWTH
TABLE 39 LASER TATTOO REMOVAL PROCEDURES: REGIONAL DISTRIBUTION (2020)
TABLE 40 DERMATOLOGY TREATMENT DEVICES MARKET FOR ACNE, PSORIASIS, AND TATTOO REMOVAL, BY REGION, 2020–2027
9.5 WRINKLE REMOVAL AND SKIN RESURFACING
9.5.1 RAPIDLY GROWING AGING POPULATION TO DRIVE SEGMENT GROWTH
TABLE 41 SKIN RESURFACING PROCEDURES: REGIONAL DISTRIBUTION (2020)
TABLE 42 DERMATOLOGY TREATMENT DEVICES MARKET FOR WRINKLE REMOVAL AND SKIN RESURFACING, BY REGION, 2020–2027
9.6 BODY CONTOURING AND FAT REMOVAL
9.6.1 RISING AWARENESS OF RECONSTRUCTIVE SURGERY TO DRIVE SEGMENT GROWTH
TABLE 43 LIPOSUCTION PROCEDURES: REGIONAL DISTRIBUTION (2020)
TABLE 44 NON-INVASIVE FAT REDUCTION (COOLSCULPTING, LIPOSONIX, EMSCULPT, VANQUISH, AND ZERONA) PROCEDURES: REGIONAL DISTRIBUTION (2020)
TABLE 45 DERMATOLOGY TREATMENT DEVICES MARKET FOR BODY CONTOURING AND FAT REMOVAL, BY REGION, 2020–2027
9.7 VASCULAR AND PIGMENTED LESION REMOVAL
9.7.1 EMERGENCE OF LASER TECHNOLOGY FOR VASCULAR LESION REMOVAL TO DRIVE SEGMENT GROWTH
TABLE 46 DERMATOLOGY TREATMENT DEVICES MARKET FOR VASCULAR AND PIGMENTED LESION REMOVAL, BY REGION, 2020–2027
9.8 WARTS, SKIN TAGS, AND WEIGHT MANAGEMENT
9.8.1 CRYOTHERAPY IS WIDELY USED IN WART AND SKIN TAG TREATMENT
TABLE 47 DERMATOLOGY TREATMENT DEVICES MARKET FOR WARTS, SKIN TAGS, AND WEIGHT MANAGEMENT, BY REGION, 2020–2027
9.9 OTHER TREATMENT APPLICATIONS
TABLE 48 DERMATOLOGY TREATMENT DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027
10 DERMATOLOGY DEVICES MARKET, BY REGION (Page No. - 120)
10.1 INTRODUCTION
TABLE 49 DERMATOLOGY DEVICES MARKET, BY REGION, 2020–2027
10.2 NORTH AMERICA
FIGURE 37 NORTH AMERICA: DERMATOLOGY DEVICES MARKET SNAPSHOT
TABLE 50 NORTH AMERICA: DERMATOLOGY DEVICES MARKET, BY COUNTRY, 2020–2027
TABLE 51 NORTH AMERICA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027
TABLE 52 NORTH AMERICA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027
TABLE 53 NORTH AMERICA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027
TABLE 54 NORTH AMERICA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027
10.2.1 US
10.2.1.1 US dominated North American market in 2021
TABLE 55 US: KEY MACROINDICATORS
TABLE 56 US: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 57 US: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 58 US: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
TABLE 59 US: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 60 US: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027
TABLE 61 US: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027
TABLE 62 US: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027
TABLE 63 US: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027
10.2.2 CANADA
10.2.2.1 Technological advancements in dermatology devices to drive market growth in Canada
TABLE 64 CANADA: KEY MACROINDICATORS
TABLE 65 CANADA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027
TABLE 66 CANADA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027
TABLE 67 CANADA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027
TABLE 68 CANADA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027
10.3 EUROPE
TABLE 69 EUROPE: DERMATOLOGY DEVICES MARKET, BY COUNTRY, 2020–2027
TABLE 70 EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027
TABLE 71 EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027
TABLE 72 EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027
TABLE 73 EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027
10.3.1 FRANCE
10.3.1.1 Laws in France regarding cosmetic surgery are restrictive as compared with those in other countries
TABLE 74 FRANCE: KEY MACROINDICATORS
TABLE 75 FRANCE: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 76 FRANCE: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 77 FRANCE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027
TABLE 78 FRANCE: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027
TABLE 79 FRANCE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027
TABLE 80 FRANCE: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027
10.3.2 GERMANY
10.3.2.1 Rising disposable income to drive dermatology device adoption in Germany
TABLE 81 GERMANY: KEY MACROINDICATORS
TABLE 82 GERMANY: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 83 GERMANY: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 84 GERMANY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
TABLE 85 GERMANY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 86 GERMANY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027
TABLE 87 GERMANY: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027
TABLE 88 GERMANY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027
TABLE 89 GERMANY: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027
10.3.3 UK
10.3.3.1 Increasing focus on facial dermatology to aid market growth
TABLE 90 UK: KEY MACROINDICATORS
TABLE 91 UK: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 92 UK: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 93 UK: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027
TABLE 94 UK: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027
TABLE 95 UK: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027
TABLE 96 UK: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027
10.3.4 ITALY
10.3.4.1 Rising number of plastic surgeons to drive market growth
TABLE 97 ITALY: KEY MACROINDICATORS
TABLE 98 ITALY: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 99 ITALY: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 100 ITALY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
TABLE 101 ITALY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 102 ITALY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027
TABLE 103 ITALY: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027
TABLE 104 ITALY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027
TABLE 105 ITALY: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027
10.3.5 SPAIN
10.3.5.1 Growing demand for cosmetic procedures to drive market growth
TABLE 106 SPAIN: KEY MACROINDICATORS
TABLE 107 SPAIN: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 108 SPAIN: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 109 SPAIN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
TABLE 110 SPAIN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 111 SPAIN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027
TABLE 112 SPAIN: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027
TABLE 113 SPAIN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027
TABLE 114 SPAIN: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027
10.3.6 REST OF EUROPE
TABLE 115 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2020 (% OF GDP)
TABLE 116 RUSSIA: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 117 REST OF EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027
TABLE 118 REST OF EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027
TABLE 119 REST OF EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027
TABLE 120 REST OF EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027
10.4 ASIA PACIFIC
FIGURE 38 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET SNAPSHOT
TABLE 121 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET, BY COUNTRY, 2020–2027
TABLE 122 ASIA PACIFIC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027
TABLE 123 ASIA PACIFIC: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027
TABLE 124 ASIA PACIFIC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027
TABLE 125 ASIA PACIFIC: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027
10.4.1 JAPAN
10.4.1.1 Japan accounted for largest share of APAC market in 2021
TABLE 126 JAPAN: KEY MACROINDICATORS
TABLE 127 JAPAN: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 128 JAPAN: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 129 JAPAN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
TABLE 130 JAPAN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 131 JAPAN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027
TABLE 132 JAPAN: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027
TABLE 133 JAPAN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027
TABLE 134 JAPAN: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027
10.4.2 CHINA
10.4.2.1 Rising healthcare expenditure to drive market growth in China
TABLE 135 CHINA: KEY MACROINDICATORS
TABLE 136 CHINA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027
TABLE 137 CHINA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027
TABLE 138 CHINA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027
TABLE 139 CHINA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027
10.4.3 INDIA
10.4.3.1 Improving healthcare infrastructure to drive market growth in India
TABLE 140 INDIA: KEY MACROINDICATORS
TABLE 141 INDIA: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 142 INDIA: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 143 INDIA: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
TABLE 144 INDIA: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 145 INDIA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027
TABLE 146 INDIA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027
TABLE 147 INDIA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027
TABLE 148 INDIA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027
10.4.4 REST OF ASIA PACIFIC
TABLE 149 THAILAND: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 150 ROAPAC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027
TABLE 151 ROAPAC: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027
TABLE 152 ROAPAC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027
TABLE 153 ROAPAC: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027
10.5 REST OF THE WORLD
TABLE 154 MEXICO: KEY MACROINDICATORS
TABLE 155 BRAZIL: KEY MACROINDICATORS
TABLE 156 BRAZIL: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 157 MEXICO: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 158 ROW: DERMATOLOGY DEVICES MARKET, BY REGION, 2020–2027
TABLE 159 ROW: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027
TABLE 160 ROW: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027
TABLE 161 ROW: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027
TABLE 162 ROW: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027
11 COMPETITIVE LANDSCAPE (Page No. - 168)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 163 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURERS
11.3 REVENUE ANALYSIS
FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN DERMATOLOGY TREATMENT DEVICES MARKET
11.4 MARKET SHARE ANALYSIS
FIGURE 40 DERMATOLOGY TREATMENT DEVICES MARKET SHARE ANALYSIS, 2020
TABLE 164 DERMATOLOGY TREATMENT DEVICES MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX (KEY PLAYERS)
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PARTICIPANTS
11.5.4 PERVASIVE PLAYERS
FIGURE 41 GLOBAL DERMATOLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
11.6 COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 42 DERMATOLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS, 2021
11.7 COMPETITIVE BENCHMARKING
TABLE 165 DERMATOLOGY DEVICES MARKET: DETAILED LIST OF KEY SMES/START-UPS
TABLE 166 DERMATOLOGY DEVICES MARKET: COMPETITIVE BENCHMARKING OF SMES/START-UPS
11.8 COMPANY FOOTPRINT
TABLE 167 OVERALL FOOTPRINT OF COMPANIES
TABLE 168 PRODUCT FOOTPRINT OF COMPANIES
TABLE 169 REGIONAL FOOTPRINT OF COMPANIES
11.9 COMPETITIVE SCENARIO AND TRENDS
11.9.1 DEALS
TABLE 170 DEALS, JANUARY 2019–MAY 2022
11.9.2 PRODUCT LAUNCHES & APPROVALS
TABLE 171 PRODUCT LAUNCHES & APPROVALS, JANUARY 2019–MAY 2022
11.9.3 EXPANSIONS
TABLE 172 EXPANSIONS, JANUARY 2019–MAY 2022
12 COMPANY PROFILES (Page No. - 185)
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 ALMA LASERS, LTD. (A SUBSIDIARY OF SISRAM MEDICAL LTD.)
TABLE 173 ALMA LASERS, LTD.: BUSINESS OVERVIEW
FIGURE 43 SISRAM MEDICAL LTD.: COMPANY SNAPSHOT (2021)
12.1.2 CUTERA, INC.
TABLE 174 CUTERA, INC.: BUSINESS OVERVIEW
FIGURE 44 CUTERA, INC.: COMPANY SNAPSHOT (2021)
12.1.3 CYNOSURE, INC.
TABLE 175 CYNOSURE, INC.: BUSINESS OVERVIEW
12.1.4 EL.EN. S.P.A.
TABLE 176 EL.EN. S.P.A.: BUSINESS OVERVIEW
FIGURE 45 EL.EN. S.P.A.: COMPANY SNAPSHOT (2021)
12.1.5 LUMENIS, LTD. (A SUBSIDIARY OF BOSTON SCIENTIFIC)
TABLE 177 LUMENIS, LTD.: BUSINESS OVERVIEW
FIGURE 46 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2021)
12.1.6 SOLTA MEDICAL (A SUBSIDIARY OF BAUSCH HEALTH COMPANIES INC.)
TABLE 178 SOLTA MEDICAL: BUSINESS OVERVIEW
FIGURE 47 BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT (2021)
12.1.7 DERMLITE
TABLE 179 DERMLITE: BUSINESS OVERVIEW
12.1.8 BRUKER CORPORATION
TABLE 180 BRUKER CORPORATION: BUSINESS OVERVIEW
FIGURE 48 BRUKER CORPORATION: COMPANY SNAPSHOT (2021)
12.1.9 CARL ZEISS
TABLE 181 CARL ZEISS: BUSINESS OVERVIEW
FIGURE 49 CARL ZEISS: COMPANY SNAPSHOT (2021)
12.1.10 GENESIS BIOSYSTEMS, INC.
TABLE 182 GENESIS BIOSYSTEMS, INC.: BUSINESS OVERVIEW
12.1.11 HEINE OPTOTECHNIK GMBH & CO. KG
TABLE 183 HEINE OPTOTECHNIK GMBH & CO. KG: BUSINESS OVERVIEW
12.1.12 MICHELSON DIAGNOSTICS, LTD.
TABLE 184 MICHELSON DIAGNOSTICS, LTD.: BUSINESS OVERVIEW
12.1.13 PHOTOMEDEX, INC. (A SUBSIDIARY OF DS HEALTHCARE GROUP)
TABLE 185 PHOTOMEDEX, INC.: BUSINESS OVERVIEW
12.1.14 FOTOFINDER SYSTEMS GMBH
TABLE 186 FOTOFINDER SYSTEMS GMBH: BUSINESS OVERVIEW
12.1.15 LEICA MICROSYSTEMS (A SUBSIDIARY OF DANAHER CORPORATION)
TABLE 187 LEICA MICROSYSTEMS: BUSINESS OVERVIEW
FIGURE 50 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
12.1.16 OLYMPUS CORPORATION
TABLE 188 OLYMPUS CORPORATION: BUSINESS OVERVIEW
FIGURE 51 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2021)
12.1.17 CANDELA CORPORATION
TABLE 189 CANDELA CORPORATION: BUSINESS OVERVIEW
FIGURE 52 CANDELA CORPORATION: COMPANY SNAPSHOT (2020)
12.1.18 CANFIELD SCIENTIFIC, INC.
TABLE 190 CANFIELD SCIENTIFIC, INC.: BUSINESS OVERVIEW
12.1.19 BEIJING TOPLASER TECHNOLOGY CO., LTD.
TABLE 191 BEIJING TOPLASER TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 SYNERON MEDICAL LTD. (A PART OF APAX PARTNERS)
12.2.2 AEROLASE
12.2.3 BOVIE (A SUBSIDIARY OF SYMMETRY SURGICAL)
TABLE 192 SYMMETRY SURGICAL: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 241)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
The study involved four major activities to estimate the current size of the dermatology devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
Several stakeholders such as dermatology device manufacturers, vendors, distributors, and physicians from hospitals and clinics were consulted for this report. The demand side of this market is characterized by increasing preference for dermatology procedures, side effects of dermatology procedures, growing geriatric population and the subsequent increase of dermatology procedures, and increasing emphasis on improving technology. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Dermatology Devices Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the dermatology devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research.
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
- All percentage shares split, and breakdowns have been determined using secondary sources and verified through primary sources.
Data Triangulation
After arriving at the overall market size-using the market size estimation processes-the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the dermatology devices industry.
Report Objectives
- To define, describe, and forecast the dermatology devices market based on product, end-user, and region.
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, and opportunities, COVID-19 Impact Analysis)
- To strategically analyze micro markets for individual growth trends, prospects, and contributions to the overall dermatology devices market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
- To forecast the size of the market segments in four geographical regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World.
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies.
- To track and analyze competitive developments such as product launches and approvals, deals, and expansions in the dermatology devices market.
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographic Analysis:
- Further breakdown of the dermatology devices market into specific countries/regions in the Rest of Europe, Rest of Asia Pacific, Middle East & African, and Latin American countries
Company Information:
-
Detailed analysis and profiling of additional market players (up to 5) inclusive of:
- Business Overview
- Financial Information
- Product Portfolio
- Developments (last three years)
Growth opportunities and latent adjacency in Dermatology Devices Market